Ryan Bethencourt
| Ryan Bethencourt | |
|---|---|
Bethencourt as a panelist at Techonomy Forum in March 2015
|
|
| Born |
Ryan Bethencourt March 18, 1979 Miami, Florida, U.S. |
| Occupation | biohacker, venture partner |
| Website | ryanbethencourt |
Ryan Bethencourt is a scientist, entrepreneur, and biohacker best known for his work as program director and venture partner at Indie.Bio, a biology accelerator and early stage seed fund. Bethencourt was head of life sciences at the XPRIZE foundation, a co-founder and CEO of Berkeley Biolabs, a biotech accelerator, and Halpin Neurosciences, an ALS therapeutics-focused biotech company. Bethencourt co-founded Counter Culture Labs, a citizen science nonprofit, and Sudo Room, a hacker space based in downtown Oakland, California.
Ryan has worked over the last decade in the biopharmaceutical industry to partner on and develop novel drugs from first IND submission to FDA approval with many major biopharmas including Pfizer, AZ, J&J, Sanofi, Takeda, Amgen, Genentech, and other companies in the U.S., E.U., and Japan. He’s also served as COO at Genescient Pharmaceuticals, a longevity focused biotech startup and CEO of Halpin Neurosciences, an ALS focused startup. Ryan’s work has been featured in Wired, TechCrunch, Forbes, the San Francisco Business Times, and other publications. He regularly speaks on biotech innovation and writes for Biocoder, an O’Reilly Media publication. He's also an author of Forbes, Techonomy and Huffington Post.
Since Ryan Bethencourt co-founded IndieBio in 2014, he and his team have funded 68 biotech startups, including companies building the post-animal bioeconomy: Clara Foods, Memphis Meats, Gelzen, New Wave, and Pembient. He's also an advisor of The Good Food Institute.
Ryan has a BSc degree in Biological Sciences (Molecular Genetics) from Warwick University in the United Kingdom. He also has a Masters in Bioscience Enterprise (MBE) from Cambridge University (2002 – 2003). This masters course was the first of its kind in the UK (launched in 2002) and it was a fusion of the MBA/Biotech courses and launched in partnership with Harvard and MIT. He's also been a Doctor of Philosophy (PhD) Candidate at the Center for Regenerative Medicine at the University of Edinburgh in 2003 working on stem cell differentiation. .
...
Wikipedia